NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹1.48 Cr | ₹1.53 Cr | ₹1.63 Cr | ₹0.63 Cr | ₹1.28 Cr |
What is the latest Short Term Provisions ratio of NGL FINECHEM ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹1.48 Cr |
| Mar2024 | ₹1.53 Cr |
| Mar2023 | ₹1.63 Cr |
| Mar2022 | ₹0.63 Cr |
| Mar2021 | ₹1.28 Cr |
How is Short Term Provisions of NGL FINECHEM Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.48 Cr | -3.20 | |
| Mar2024 | ₹1.53 Cr | -6.02 | |
| Mar2023 | ₹1.63 Cr | 159.49 | |
| Mar2022 | ₹0.63 Cr | -50.90 | |
| Mar2021 | ₹1.28 Cr | - | |
Compare Short Term Provisions of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹884.4 Cr | 1.2% | 8.6% | -21.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,319.0 Cr | 2.4% | -2.5% | -7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,383.0 Cr | 3.9% | 2.6% | 3.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,241.0 Cr | 2.5% | 4.1% | 12.3% | Stock Analytics | |
| CIPLA | ₹123,617.0 Cr | 1.3% | 0.6% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,825.0 Cr | -1.2% | -1.5% | -9.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 1.2% |
8.6% |
-21.1% |
| SENSEX | 0.5% |
-0.2% |
8.4% |
You may also like the below Video Courses